BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7514816)

  • 1. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
    Minamikawa K; Wada H; Wakita Y; Ohiwa M; Tanigawa M; Deguchi K; Hiraoka N; Huzioka H; Nishioka J; Hayashi T
    Thromb Haemost; 1994 Feb; 71(2):192-4. PubMed ID: 7514816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
    Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis.
    Yamada N; Wada H; Nakase T; Minamikawa K; Nagaya S; Nakamura M; Hiraoka N; Fuzioka H; Hayashi T; Suzuki K
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):627-33. PubMed ID: 8562833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
    Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of haemostatic markers in various subtypes and phases of stroke.
    Yamazaki M; Uchiyama S; Maruyama S
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
    Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.
    Gabazza EC; Osamu T; Yamakami T; Ibata H; Sato T; Sato Y; Shima T
    Thromb Haemost; 1994 Feb; 71(2):199-202. PubMed ID: 7514817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].
    Shiiki M; Ariyoshi N; Nakamura T; Shirahata A
    Rinsho Ketsueki; 1991 Jul; 32(7):758-65. PubMed ID: 1833569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
    Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
    J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
    Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
    Sugimura M; Kobayashi T; Kanayama N; Terao T
    Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR; Langley PG; Hughes RD; Izumi S; Williams R
    Hepatology; 1993 Dec; 18(6):1350-6. PubMed ID: 8244260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.